Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy in myocardial infarction.

Sara D Collins1, Richard Baffour, Ron Waksman

  • 1Department of Internal Medicine, University of Maryland Medical Center, Baltimore, MD, USA.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|February 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovative use of self-expanded polytetrafluoroethylene endoprosthesis for percutaneous endovascular interventions.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2012
Same author

Safety and efficacy of everolimus-eluting stents versus sirolimus-eluting stents in women.

The American journal of cardiology·2012
Same author

Transcatheter "thrombin-blood patch" injection: a novel and effective approach to treat catheterization-related arterial perforation.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2012
Same author

Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2012
Same author

Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stent.

Cardiovascular revascularization medicine : including molecular interventions·2012
Same author

The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2012

Cell therapy shows promise for heart failure by replacing damaged heart tissue. However, early clinical trial results are inconsistent, indicating further research is needed for this potential treatment.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Heart failure presents significant morbidity and mortality.
  • Current treatments may not halt adverse myocardial remodeling.
  • Cell therapy offers a potential strategy to repair damaged heart muscle.

Purpose of the Study:

  • To review the current state of cell therapy for heart failure.
  • To explore proposed mechanisms of action for cell-based treatments.
  • To assess the clinical efficacy and future directions of cell therapy in heart failure.

Main Methods:

  • Review of existing literature on cell therapy in heart failure models.
  • Analysis of various stem cell types (e.g., bone marrow-derived stem cells, skeletal myoblasts).

Related Experiment Videos

  • Examination of different delivery routes and proposed therapeutic mechanisms (transdifferentiation, fusion, paracrine effects).
  • Main Results:

    • Multiple stem cell types and delivery methods have been investigated.
    • Proposed mechanisms include cell replacement, fusion, and paracrine signaling.
    • Early promising clinical results have not been consistently replicated in larger studies.

    Conclusions:

    • Cell therapy holds theoretical potential for treating heart failure.
    • The precise mechanisms of benefit require further elucidation.
    • Robust clinical evidence is lacking, necessitating more research before widespread adoption.